Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease.

Amara AW, Walker HC, Joop A, Cutter G, DeWolfe JL, Harding SM, Standaert DG.

Mov Disord Clin Pract. 2017 Mar-Apr;4(2):183-190. doi: 10.1002/mdc3.12375. Epub 2016 Jun 6.

PMID:
28924578
2.

Does Dopamine Depletion Trigger a Spreader Lexical-Semantic Activation in Parkinson's Disease? Evidence from a Study Based on Word Fluency Tasks.

Zabberoni S, Carlesimo GA, Peppe A, Caltagirone C, Costa A.

Parkinsons Dis. 2017;2017:2837685. doi: 10.1155/2017/2837685. Epub 2017 Jun 11.

3.

Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson's disease.

Su XL, Luo XG, Lv H, Wang J, Ren Y, He ZY.

Transl Neurodegener. 2017 May 26;6:14. doi: 10.1186/s40035-017-0084-6. eCollection 2017.

4.

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication.

Chung JW, Burciu RG, Ofori E, Shukla P, Okun MS, Hess CW, Vaillancourt DE.

Neuroimage Clin. 2017 Feb 16;14:417-421. doi: 10.1016/j.nicl.2017.02.012. eCollection 2017.

5.

The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease.

Birchall EL, Walker HC, Cutter G, Guthrie S, Joop A, Memon RA, Watts RL, Standaert DG, Amara AW.

Brain Stimul. 2017 May - Jun;10(3):651-656. doi: 10.1016/j.brs.2016.12.014. Epub 2016 Dec 27.

PMID:
28065487
6.

Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial.

Rafferty MR, Prodoehl J, Robichaud JA, David FJ, Poon C, Goelz LC, Vaillancourt DE, Kohrt WM, Comella CL, Corcos DM.

J Neurol Phys Ther. 2017 Jan;41(1):21-30.

7.

Are the average gait speeds during the 10meter and 6minute walk tests redundant in Parkinson disease?

Duncan RP, Combs-Miller SA, McNeely ME, Leddy AL, Cavanaugh JT, Dibble LE, Ellis TD, Ford MP, Foreman KB, Earhart GM.

Gait Posture. 2017 Feb;52:178-182. doi: 10.1016/j.gaitpost.2016.11.033. Epub 2016 Nov 22.

PMID:
27915221
8.

The Practicalities of Assessing Freezing of Gait.

Barthel C, Mallia E, Debû B, Bloem BR, Ferraye MU.

J Parkinsons Dis. 2016 Oct 19;6(4):667-674. Review.

9.

Progressive resistance exercise restores some properties of the triphasic EMG pattern and improves bradykinesia: the PRET-PD randomized clinical trial.

David FJ, Robichaud JA, Vaillancourt DE, Poon C, Kohrt WM, Comella CL, Corcos DM.

J Neurophysiol. 2016 Nov 1;116(5):2298-2311. doi: 10.1152/jn.01067.2015. Epub 2016 Aug 31.

10.

Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes.

Burciu RG, Chung JW, Shukla P, Ofori E, Li H, McFarland NR, Okun MS, Vaillancourt DE.

Neurology. 2016 Aug 16;87(7):709-17. doi: 10.1212/WNL.0000000000002985. Epub 2016 Jul 15.

11.

Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease.

Sterling NW, Lichtenstein M, Lee EY, Lewis MM, Evans A, Eslinger PJ, Du G, Gao X, Chen H, Kong L, Huang X.

Aging Dis. 2016 May 27;7(3):237-45. doi: 10.14336/AD.2015.1030. eCollection 2016 May.

12.

Default mode network differences between rigidity- and tremor-predominant Parkinson's disease.

Karunanayaka PR, Lee EY, Lewis MM, Sen S, Eslinger PJ, Yang QX, Huang X.

Cortex. 2016 Aug;81:239-50. doi: 10.1016/j.cortex.2016.04.021. Epub 2016 May 6.

13.

Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.

Li W, Englund E, Widner H, Mattsson B, van Westen D, Lätt J, Rehncrona S, Brundin P, Björklund A, Lindvall O, Li JY.

Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):6544-9. doi: 10.1073/pnas.1605245113. Epub 2016 May 2.

14.

Free-water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO-B inhibitor.

Burciu RG, Ofori E, Shukla P, Pasternak O, Chung JW, McFarland NR, Okun MS, Vaillancourt DE.

Hum Brain Mapp. 2016 Aug;37(8):2894-903. doi: 10.1002/hbm.23213. Epub 2016 Apr 19.

15.

The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Lewis MM, Du G, Lee EY, Nasralah Z, Sterling NW, Zhang L, Wagner D, Kong L, Tröster AI, Styner M, Eslinger PJ, Mailman RB, Huang X.

J Neurol. 2016 Jan;263(1):68-75. doi: 10.1007/s00415-015-7929-7.

16.

Reduced Verbal Fluency following Subthalamic Deep Brain Stimulation: A Frontal-Related Cognitive Deficit?

Houvenaghel JF, Le Jeune F, Dondaine T, Esquevin A, Robert GH, Péron J, Haegelen C, Drapier S, Jannin P, Lozachmeur C, Argaud S, Duprez J, Drapier D, Vérin M, Sauleau P.

PLoS One. 2015 Oct 8;10(10):e0140083. doi: 10.1371/journal.pone.0140083. eCollection 2015.

17.

Machine learning classification of medication adherence in patients with movement disorders using non-wearable sensors.

Tucker CS, Behoora I, Nembhard HB, Lewis M, Sterling NW, Huang X.

Comput Biol Med. 2015 Nov 1;66:120-34. doi: 10.1016/j.compbiomed.2015.08.012. Epub 2015 Sep 8.

18.

Change in motor function and adverse health outcomes in older African-Americans.

Buchman AS, Wilson RS, Leurgans SE, Bennett DA, Barnes LL.

Exp Gerontol. 2015 Oct;70:71-7. doi: 10.1016/j.exger.2015.07.009. Epub 2015 Jul 21.

19.

Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial.

David FJ, Robichaud JA, Leurgans SE, Poon C, Kohrt WM, Goldman JG, Comella CL, Vaillancourt DE, Corcos DM.

Mov Disord. 2015 Oct;30(12):1657-63. doi: 10.1002/mds.26291. Epub 2015 Jul 6.

20.

Rasagiline and rapid symptomatic motor effect in Parkinson's disease: review of literature.

Pistacchi M, Martinello F, Gioulis M, Zambito Marsala S.

Neurol Ther. 2013 Dec 17;3(1):41-66. doi: 10.1007/s40120-013-0014-1. eCollection 2014 Jun. Review.

Supplemental Content

Support Center